Precision Oncology 
Contract Research Organization
  • Home
  • Data
  • Sequencing
  • Cdx Dev
  • OMICS
  • Full Service CRO
  • Bio-Assays
  • Patients
  • About
  • Contact
  • More
    • Home
    • Data
    • Sequencing
    • Cdx Dev
    • OMICS
    • Full Service CRO
    • Bio-Assays
    • Patients
    • About
    • Contact
Precision Oncology 
Contract Research Organization
  • Home
  • Data
  • Sequencing
  • Cdx Dev
  • OMICS
  • Full Service CRO
  • Bio-Assays
  • Patients
  • About
  • Contact

About Us

 Arrant has created a worldwide establishment of Laboratories, Hospitals, Oncologists, a Captive Audience of Patients & a Full Service CRO to Accelerate Precision Oncology R&D

Arrant is currently conducting one of the largest cancer genome sequencing research projects in the world to understand the true biology of cancer. 

Arrant's establishment promotes collaborations with biopharma from bio marker discovery to clinical trials.

LEADERSHIP

Jamal Naiyer

John Spitznagel

John Spitznagel

Founder and CEO.


Physician Scientist with 25 years of experience in bio-medical science and healthcare delivery


Domain experience in Precision Oncology & Medical Data


Training & experience at Cornell & Columbia University Hospitals

John Spitznagel

John Spitznagel

John Spitznagel

25+ years experience in Healthcare Company Building and Execution – Business and Team Builder


Experience in business development – fund raising to partnership/exit


Maximizing Shareholder Value


Launched and Relaunched over two dozen companies and products with success

Ranjeet Nabha

John Spitznagel

Trenton Bieront

Mr. Ranjeet Nabha is a senior executive who has led organizations in the areas of Private Equity, Technology and Corporate Advisory. His areas of expertise include investment management, business development, general management, and technology entrepreneurship.


Prior to these roles, he was a Managing Director at WL Ross & Co. a global priv

Mr. Ranjeet Nabha is a senior executive who has led organizations in the areas of Private Equity, Technology and Corporate Advisory. His areas of expertise include investment management, business development, general management, and technology entrepreneurship.


Prior to these roles, he was a Managing Director at WL Ross & Co. a global private equity firm, and CEO of WL Ross’ private equity business in India. 


He also served as Vice President at J.P. Morgan &Co. in New York where he advised on restructurings, mergers/acquisitions, capital raisings and privatizations.


Mr. Nabha earned his MBA at the Tuck School of Business at Dartmouth College.

Trenton Bieront

Trenton Bieront

Trenton Bieront

Over 40 years of diversified experience, specializing in pharmaceuticals, biotechnology, diagnostics, medical devices, and healthcare services


Proven strengths in leveraging scientific knowledge, analytical/strategic thinking,
market/customer understanding, and the leadership skills to transform insights
into innovative commercial strategi

Over 40 years of diversified experience, specializing in pharmaceuticals, biotechnology, diagnostics, medical devices, and healthcare services


Proven strengths in leveraging scientific knowledge, analytical/strategic thinking,
market/customer understanding, and the leadership skills to transform insights
into innovative commercial strategies and tactics


Played an instrumental role in numerous highly successful product and brand launches, with numerous awards for business excellence


Marketing expertise across entire lifecycle continuum. Extensive experience across several therapeutic areas.

Tariq Naiyer

Trenton Bieront

Tariq Naiyer

Lawyer, Entrepreneur and promoter.


Solid background and entrepreneurial management experience in leading the development of business and marketing. Extensive network of contacts gathered in India and the United States.

Reviews


Copyright © 2024 Arrant Laboratories - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept